REVIUM Rx. Stock-Based Compensation
REVIUM Rx. (RVRC) reported Stock-Based Compensation of $111.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-13
- REVIUM Rx. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $154.00K.
- REVIUM Rx. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $340.00K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month |
|---|---|---|
| 2026-06-30 | $111.00K 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $494.00K 10-Q · filed 2026-08-13 |
| 2025-03-31 | $340.00K 10-Q · filed 2026-05-14 |